Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LUCID-MS / FSD Pharma
NCT05821387: Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers	Completed	1	40	Canada	Lucid-21-302, Placebo	FSD Pharma, Inc., Lucid Psycheceuticals Inc. (sub of FSD Pharma, Inc.)	Healthy Participants	07/23	07/23
NCT06595706: Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants	Not yet recruiting	1	16	RoW	Lucid-21-302, Placebo	FSD Pharma, Inc., Huge Biopharma Australia Pty Ltd	Heathy Participants	01/25	01/25